Get the Stockscreener App
4.19
5.84%
-0.26
Exicure Inc stock is traded at $4.19, with a volume of 60,318.
It is down -5.84% in the last 24 hours and down -30.05% over the past month.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
See More
Previous Close:
$4.45
Open:
$4.58
24h Volume:
60,318
Relative Volume:
0.10
Market Cap:
$26.71M
Revenue:
$500.00K
Net Income/Loss:
$-7.88M
P/E Ratio:
-2.4734
EPS:
-1.694
Net Cash Flow:
$-5.49M
1W Performance:
-33.28%
1M Performance:
-30.05%
6M Performance:
-41.97%
1Y Performance:
-63.63%
1-Day Range:
$4.15
$4.58
1-Week Range:
$4.15
$6.645
52-Week Range:
$3.1006
$15.91
Exicure Inc Stock (XCUR) Company Profile
Name
Exicure Inc
Sector
Industry
Phone
847-673-1707
Address
2430 N. HALSTED ST., CHICAGO, IL
Compare XCUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.625 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
4.25 | 6.26B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
9.02 | 481.52M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.36 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.86 | 264.10M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
47.03 | 0 | 0 | 0 | 0 | 0.00 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Dec-18-20 | Initiated | BMO Capital Markets | Outperform |
| Nov-20-19 | Initiated | Guggenheim | Buy |
Exicure Inc Stock (XCUR) Latest News
Trade Report: What is the Moat Score of Exicure Inc2025 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up - TipRanks
Exicure completes Phase 2 trial milestone and plans $1 million payment to GPCR Therapeutics - Investing.com UK
Exicure to Pay GPCR Therapeutics $1 Million for First Milestone Completion - 아시아경제
Exicure Achieves Milestone in Burixafor Phase 2 Program - TipRanks
Exicure Achieves First Milestone in Collaboration with GPCR Therapeutics - TradingView
Exicure to present phase 2 burixafor data at 2026 transplantation meeting - Investing.com Nigeria
Major Exicure Stakeholder Makes Bold Move With Large Share Sale - TipRanks
Insider Sell: Hitron Exicure Sells 258,367 Shares of Exicure Inc (XCUR) - GuruFocus
Exicure HiTron sells shares worth $1.16 million By Investing.com - Investing.com Nigeria
Exicure HiTron sells shares worth $1.16 million - Investing.com
Exicure to present data from burixafor Phase 2 trial at 2026 Tandem Meetings - TipRanks
Exicure (XCUR) to Showcase Phase 2 Trial Data on Burixafor at 20 - GuruFocus
Exicure, Inc. to Present Phase 2 Trial Results for Burixafor at 2026 ASTCT and CIBMTR Tandem Meetings - Quiver Quantitative
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings - The Manila Times
Exicure to Present Data From Burixafor Phase 2 Trial at the 2026 Tandem Meetings - 富途牛牛
Major Exicure Stakeholder Makes a Big Move With a Multi-Million Dollar Stock Sale - TipRanks
Exicure HiTron Inc sells $3.3m in Exicure (XCUR) stock By Investing.com - Investing.com Nigeria
Signal Recap: Whats the outlook for Exicure Incs sectorWeekly Trade Report & AI Based Buy and Sell Signals - baoquankhu1.vn
Insider Sell Alert: Hitron Exicure Sells 734,747 Shares of Exicu - GuruFocus
Exicure HiTron Inc sells $3.3m in Exicure (XCUR) stock - Investing.com
Understanding Momentum Shifts in (XCUR) - Stock Traders Daily
Exicure (NASDAQ:XCUR) Stock Rating Upgraded by Wall Street Zen - Defense World
Exicure, Inc. (NASDAQ:XCUR) Short Interest Down 42.7% in December - Defense World
Exicure (NASDAQ:XCUR) Shares Up 1.2% – Time to Buy? - Defense World
Insider Sale: 10% owner at $XCUR Sells 741,272 Shares | XCUR Stock News - Quiver Quantitative
Why Exicure Inc. (2H0) stock attracts HNW investorsJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - Улправда
Exicure presents topline data from burixafor combination trial - MSN
Exicure HiTron sells $3.3m in Exicure shares By Investing.com - Investing.com South Africa
Exicure Hitron Sells Over 740K Shares - TradingView — Track All Markets
Exicure HiTron sells $3.3m in Exicure shares - Investing.com
Why Exicure Inc. stock is rated strong buyMarket Growth Review & Daily Stock Trend Watchlist - ulpravda.ru
Avoiding Lag: Real-Time Signals in (XCUR) Movement - Stock Traders Daily
Bond Watch: Why Exicure Inc 2H0 stock attracts HNW investorsWeekly Loss Report & Low Volatility Stock Suggestions - Bộ Nội Vụ
Aug Highlights: Is Exicure Inc 2H0 stock worth buying before Fed actionWeekly Risk Report & Verified Short-Term Trading Plans - moha.gov.vn
Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know - ts2.tech
Promising Biotech Stocks To Keep An Eye OnDecember 9th - MarketBeat
Buyback Watch: Is Exicure Inc 2H0 stock worth buying before Fed action2025 Key Highlights & Free Fast Gain Swing Trade Alerts - moha.gov.vn
Exicure Regains Nasdaq Compliance as of July 2025 - The Globe and Mail
Trading Action: Why Exicure Inc stock is rated strong buyAnalyst Downgrade & Free High Accuracy Swing Entry Alerts - moha.gov.vn
(XCUR) Risk Channels and Responsive Allocation - Stock Traders Daily
Exicure Hitron To Sell 14.8 Billion Won Stake In Exicure Inc - TradingView
Will Exicure Inc. stock benefit from upcoming earnings reportsM&A Rumor & Accurate Intraday Trading Signals - DonanımHaber
Is Exicure Inc. stock ready for breakoutMarket Trend Review & Technical Confirmation Trade Alerts - ulpravda.ru
Exicure Inc Stock (XCUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.49%
4.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):